Just found an article and a medical journal on American Diabetes Association regarding JAK1 inhibitor.
It seems promising. JDRF has been funding research into JAK for years. And now still on research from 2018 until 2021.
https://researchdata.edu.au/repurposing-jak-inhibitors-1-diabetes/1320460
Does anyone has more information?
Thank You